🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this research study is to determine the maximum tolerab...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2020-11-23
Trial ID
NCT04477343
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2018-05-14
Trial ID
NCT03522246
Treatments Being Tested
The primary objective is to assess the activity and efficacy of pembrolizum...
Status
Active Not Recruiting
Location
San Francisco VA Medical Center, San Francisco, CA
Start Date
2020-02-20
Trial ID
NCT04104893
Treatments Being Tested
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This trial is a registrational Phase III, randomized, open-label, multicent...
Status
Not Yet Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2026-09
Trial ID
NCT07783321
Treatments Being Tested
This is a multicenter, open-label, single-arm, prospective clinical study o...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-02-07
Trial ID
NCT07410520
Treatments Being Tested
This is a study of the combination of 9 ING-41 (elraglusib) and retifanlima...
Status
Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2025-09-22
Trial ID
NCT06896188
Treatments Being Tested
To assess the efficacy and safety of TQB2450 in combination with anlotinib ...
Status
Unknown
Location
Cancer Hospital Affiliated to Shandong First Medical University
Start Date
2023-05-30
Trial ID
NCT05942508
Treatments Being Tested
This clinical trial will evaluate the combination of quaratusugene ozeplasm...
Status
Recruiting
Location
Rocky Mountain Cancer Centers, LLP
Start Date
2024-05-09
Trial ID
NCT05703971
Treatments Being Tested